Kelleher, Dennis et al
"Phase II study of once-daily GSK573719 inhalation powder, a new long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD)." European Respiratory Journal
38.Suppl 55
(2011):
p834.
Web. 19 April. 2024.